Eledon Pharmaceuticals Announces Dosing of 10th Patient in Ongoing Phase 1b Trial Evaluating Tegoprubart in Patients Undergoing Kidney Transplantation
16 août 2023 07h00 HE
|
Eledon Pharmaceuticals, Inc.
10th patient dosed marks achievement of first clinical milestone associated with next tranche of funding Eledon to report updated interim clinical data from the ongoing Phase 1b trial of tegoprubart...
Eledon Pharmaceuticals Reports Second Quarter 2023 Operating and Financial Results
10 août 2023 07h00 HE
|
Eledon Pharmaceuticals, Inc.
Ninth patient dosed in ongoing Phase 1b trial evaluating tegoprubart in patients undergoing kidney transplantation; updated clinical data expected in the fourth quarter Raised up to $185 million,...
American Kidney Fund Announces $250,000 Grant from the Robert I. Schattner Foundation in Support of Pediatric Kidney Disease Programs and Safety Net Grants
05 juil. 2023 09h11 HE
|
American Kidney Fund
ROCKVILLE, Md., July 05, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is pleased to announce a $250,000 grant from the Robert I. Schattner Foundation, a private charitable foundation...
Eledon Pharmaceuticals to Present at Jefferies Healthcare Conference
02 juin 2023 08h00 HE
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., June 02, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, will present...
American Kidney Fund Activates Disaster Relief Program to Support Dialysis and Post-Transplant Patients Affected by Typhoon Mawar
25 mai 2023 09h03 HE
|
American Kidney Fund
ROCKVILLE, Md., May 25, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) has turned on its Disaster Relief Program to administer emergency grants to dialysis and post-transplant patients who...
American Kidney Fund’s Kidney Action Summit Brings AKF Ambassadors to Capitol Hill to Urge Congress to Protect Living Donors and Boost Funding for Kidney Disease Research
16 mai 2023 08h30 HE
|
American Kidney Fund
ROCKVILLE, Md., May 16, 2023 (GLOBE NEWSWIRE) -- More than two dozen American Kidney Fund (AKF) Ambassadors – kidney patients, caregivers and living donors from across the country – will meet with...
Eledon Pharmaceuticals Reports First Quarter 2023 Operating and Financial Results
11 mai 2023 16h01 HE
|
Eledon Pharmaceuticals, Inc.
Reported open-label data from ongoing Phase 1b trial of tegoprubart in kidney transplantation demonstrating mean eGFRs from 3 participants above 70 mL/min/1.73m2 at measured timepoints Completed...
American Kidney Fund Will Host Cystinosis Camp as Part of National Virtual Camp for Children and Teens with Kidney Disease
08 mai 2023 09h33 HE
|
American Kidney Fund
ROCKVILLE, Md., May 08, 2023 (GLOBE NEWSWIRE) -- This fall, the American Kidney Fund will be offering special programming specifically for children with cystinosis during its much-loved national...
Eledon Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
04 mai 2023 16h05 HE
|
Eledon Pharmaceuticals, Inc.
IRVINE, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that it plans to release financial results for the first quarter ended March...
Eledon Pharmaceuticals Announces up to $185 Million Financing to Advance Tegoprubart Kidney Transplantation Clinical Trials
01 mai 2023 07h00 HE
|
Eledon Pharmaceuticals, Inc.
$35 million in upfront financing with the potential to receive additional aggregate financing up to $105 million, subject to achieving clinical development milestones, plus up to $45 million upon...